More articles from 05.01 - Airway pharmacology and treatment

Dupilumab leads to sustained improvement of asthma control in real-life severe asthmatics.
A Renner, K Marth, K Patocka, M Idzko, W Pohl

European Respiratory Journal Sep 2022, 60 (suppl 66) 3415; DOI: 10.1183/13993003.congress-2022.3415
Association between sub-optimal medication adherence and risk of COPD diagnosis in patients with physician-diagnosed asthma: A propensity score-based analysis
M Asamoah-Boaheng, J Farrell, K O Bonsu, A Oyet, W K Midodzi

European Respiratory Journal Sep 2022, 60 (suppl 66) 3394; DOI: 10.1183/13993003.congress-2022.3394
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
W Chen, T N Tran, M Sadatsafavi, E Garcia Gil, M Alacqua, A Menzies Gow, L G Heaney, P E.Pfeffer, J Maspero, M Peters, G C Christoff, M Bhutani, C A.Torres-Duque, C Ulrik, A Altraja, L Lehtimaki, C Taille, A I.Papaioannou, S Salvi, R W Costello, G Walter Canonica, T Iwanaga, M Al-Ahmad, D Larenas-Linnemann, P Kuna, J A.Fonseca, R Al-Lehebi, M Koh Siyue, C K Rhee, L Perez-De-Llano, R C Jones, D Perng, E Wang, F Hoyte, N Wong Chong Boon, J Lyu, C Ariti, R Murray, C Goh, I Joshi, N Eleangovan, D Price

European Respiratory Journal Sep 2022, 60 (suppl 66) 3405; DOI: 10.1183/13993003.congress-2022.3405
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
S Burkill, C M. Porsbjerg, A Bourdin, T N Tran, N Martin, R Katial, P Barker, M E Wechsler, J Maspero, S Bosnic-Anticevich, L P Chung, G Katsoulotos, G C Christoff, T A Popov, M Sadatsafavi, C A Torres-Duque, C Ulrik, K Dahl Assing, S Hansen, A Altraja, L A Lehtimaki, N G Papadopoulos, K Kostikas, S Salvi, R W Costello, P Francesca, T Iwanaga, C K Rhee, M Al-Ahmad, D Larenas-Linnemann, J A Fonseca, R Amaral, K Alving, R Al-Lehebi, L Perez De-Llano, B Kirenga, M Tsai, B Mahboub, P E Pfeffer, W Henley, Y Liu, J Lyu, C Goh, T Uthaman, D Price, J Townend

European Respiratory Journal Sep 2022, 60 (suppl 66) 3305; DOI: 10.1183/13993003.congress-2022.3305
How does Arg16Gly polymorphism affect pulmonary function and treatment response in COPD patients?
N Slepchenko, Y Mostovoy, K Dmytriiev, Y Smereka, D Dmytriiev

European Respiratory Journal Sep 2022, 60 (suppl 66) 3429; DOI: 10.1183/13993003.congress-2022.3429
Dupilumab effectiveness in patients with type 2-high severe asthma and chronic rhinosinusitis with nasal polyps
S Nolasco, R Campisi, A Cipolla, P Impellizzeri, M Bonsignore, N Crimi, C Crimi

European Respiratory Journal Sep 2022, 60 (suppl 66) 3319; DOI: 10.1183/13993003.congress-2022.3319
The availability, cost and affordability of essential medicines for asthma and COPD in low- and middle-income countries: A systematic review
M Stolbrink, H Thomson, R M Hadfield, O B Ozoh, R Nantanda, S Jayasooria, B Allwood, D M Halpin, S Salvi, M Montes De Oca, K Mortimer*, S Rylance*

European Respiratory Journal Sep 2022, 60 (suppl 66) 3525; DOI: 10.1183/13993003.congress-2022.3525
Association between dietary fibre, microbial metabolites and airway obstruction in COPD patients and murine models
K Budden, S F Rehman, S Shukla, K Bowerman, C Donovan, H Gomez, C Alemao, L Wood, P Dennis, P Hugenholtz, P Wark, P Hansbro

European Respiratory Journal Sep 2022, 60 (suppl 66) 3289; DOI: 10.1183/13993003.congress-2022.3289
Recombinant AAT-Fc fusion protein INBRX-101 achieves normal serum AAT levels in patients with alpha-1 antitrypsin deficiency (AATD)
A Veale, H Farah, R Mahadeva, M Baker, B Kuhn, A Cole, C Chang, C Brown, M Campos, J Kalabus, T Boyea, C Veldstra, V Andrianov, S Bhagwat, B P Eckelman, J Loscano, M Brantly

European Respiratory Journal Sep 2022, 60 (suppl 66) 3599; DOI: 10.1183/13993003.congress-2022.3599
The differential synergistic injurious effect of resistive breathing on pulmonary and extra-pulmonary lung injury
D Toumpanakis, K Glynos, V Vassilakopoulou, A Chatzianastasiou, E Mizi, M Dettoraki, F Perlikos, C Magkou, A Papapetropoulos, T Vassilakopoulos

European Respiratory Journal Sep 2022, 60 (suppl 66) 3507; DOI: 10.1183/13993003.congress-2022.3507

Main menu

User menu

Search

More articles from 05.01 - Airway pharmacology and treatment

Pages

Contact us